Brighton Jones LLC Bluebird Bio, Inc. Transaction History

Brighton Jones LLC

$2.55 Billion
Q3 2024

A detailed history of Brighton Jones LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Brighton Jones LLC holds 23,174 shares of BLUE stock, worth $8,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,174

Previous 25,720 9.9%

Holding current value

$8,110

Previous $25,000 52.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$0.47 - $1.35 $1,196 - $3,437	-2,546 Reduced 9.9%	23,174 $12,000
Q1 2024 May 09, 2024	BUY	$0.91 - $1.75 $1,502 - $2,889	1,651 Added 6.86%	25,720 $32,000
Q4 2023 Feb 05, 2024	SELL	$1.32 - $4.83 $198 - $724	-150 Reduced 0.62%	24,069 $33,000
Q3 2023 Oct 25, 2023	SELL	$3.02 - $4.05 $1,482 - $1,988	-491 Reduced 1.99%	24,219 $73,000
Q2 2023 Jul 31, 2023	SELL	$2.79 - $5.03 $7,948 - $14,330	-2,849 Reduced 10.34%	24,710 $81,000
Q3 2022 Nov 09, 2022	BUY	$3.75 - $7.39 $1,841 - $3,628	491 Added 1.81%	27,559 $174,000
Q2 2022 Aug 04, 2022	SELL	$2.94 - $5.23 $382 - $679	-130 Reduced 0.48%	27,068 $112,000
Q1 2022 May 13, 2022	BUY	$4.07 - $10.6 $529 - $1,378	130 Added 0.48%	27,198 $132,000
Q4 2021 Feb 03, 2022	SELL	$8.96 - $16.31 $4,623 - $8,415	-516 Reduced 1.87%	27,068 $270,000
Q3 2021 Nov 04, 2021	SELL	$11.24 - $21.0 $618 - $1,155	-55 Reduced 0.2%	27,584 $527,000
Q2 2021 Aug 10, 2021	BUY	$18.04 - $22.09 $22,026 - $26,971	1,221 Added 4.62%	27,639 $884,000
Q1 2021 May 07, 2021	BUY	$16.59 - $33.89 $4,678 - $9,556	282 Added 1.08%	26,418 $797,000
Q4 2020 Feb 10, 2021	SELL	$27.5 - $37.92 $1,100 - $1,516	-40 Reduced 0.15%	26,136 $1.13 Million
Q3 2020 Nov 12, 2020	BUY	$34.44 - $43.75 $52,279 - $66,412	1,518 Added 6.16%	26,176 $1.41 Million
Q2 2020 Aug 11, 2020	BUY	$27.12 - $45.97 $759 - $1,287	28 Added 0.11%	24,658 $1.51 Million
Q1 2020 May 13, 2020	SELL	$26.16 - $63.5 $654 - $1,587	-25 Reduced 0.1%	24,630 $1.13 Million
Q4 2019 Feb 07, 2020	BUY	$46.96 - $61.67 $375 - $493	8 Added 0.03%	24,655 $2.16 Million
Q2 2019 Aug 05, 2019	BUY	$75.84 - $105.21 $23,662 - $32,825	312 Added 1.28%	24,647 $3.14 Million
Q1 2019 Apr 26, 2019	BUY	$64.44 - $104.11 $515 - $832	8 Added 0.03%	24,335 $3.83 Million
Q4 2018 Feb 08, 2019	BUY	$59.1 - $93.26 $2,541 - $4,010	43 Added 0.18%	24,327 $2.41 Million
Q3 2018 Nov 07, 2018	SELL	$88.86 - $117.49 $123,071 - $162,723	-1,385 Reduced 5.4%	24,284 $3.55 Million
Q2 2018 Aug 06, 2018	BUY	$99.64 - $127.59 $298 - $382	3 Added 0.01%	25,669 $4.03 Million
Q1 2018 May 03, 2018	SELL	$105.8 - $150.94 $1.01 Million - $1.44 Million	-9,515 Reduced 27.05%	25,666 $4.38 Million
Q4 2017 Feb 08, 2018	BUY	$81.25 - $130.7 $111,231 - $178,928	1,369 Added 4.05%	35,181 $6.27 Million
Q2 2017 Aug 08, 2017	BUY	N/A	33,812	33,812 $3.55 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Account

Brighton Jones LLC Bluebird Bio, Inc. Transaction History